Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. G1t38
2. 1628256-23-4
3. G1t38 Free Base
4. Lerociclib [usan]
5. Wbh8ay6enb
6. G1t-38
7. Lerociclib (usan)
8. 4-[[5-(4-propan-2-ylpiperazin-1-yl)pyridin-2-yl]amino]spiro[1,3,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1'-cyclohexane]-10-one
9. 2'-((5-(4-isopropylpiperazin-1-yl)pyridin-2-yl)amino)-7',8'-dihydro-6'h-spiro[cyclohexane-1,9'-pyrazino[1',2':1,5]pyrrolo[2,3-d]pyrimidin]-6'-one
10. 7',8'-dihydro-2'-((5-(4-(1-methylethyl)-1-piperazinyl)-2-pyridinyl)amino)spiro(cyclohexane-1,9'(6'h)-pyrazino(1',2':1,5)pyrrolo(2,3-d)pyrimidin)-6'-one
11. Spiro(cyclohexane-1,9'(6'h)-pyrazino(1',2':1,5)pyrrolo(2,3-d)pyrimidin)-6'-one, 7',8'-dihydro-2'-((5-(4-(1-methylethyl)-1-piperazinyl)-2-pyridinyl)amino)-
12. G1t38; Lerociclib
13. Unii-wbh8ay6enb
14. Lerociclib [inn]
15. Lerociclib [who-dd]
16. Chembl3904602
17. Schembl16036885
18. Gtpl10313
19. Bdbm253941
20. Example Gg [us9464092b2]
21. Bcp26063
22. Ex-a3076
23. S8568
24. Zb1560
25. Us9464092, Gg
26. Ac-36315
27. Hy-112272
28. Cs-0044656
29. D11455
30. A901869
31. G1t38; G1t-38; G1t 38; G1-t38; G1 T-38; G1 T38
32. 2'-((5-(4-(propan-2-yl)piperazin-1-yl)pyridin-2-yl)amino)-7',8'-dihydrospiro(cyclohexane-1,9'(6'h)-pyrazino(1',2':1,5)pyrrolo(2,3-d)pyrimidin)-6'-one
| Molecular Weight | 474.6 g/mol |
|---|---|
| Molecular Formula | C26H34N8O |
| XLogP3 | 3.4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 4 |
| Exact Mass | 474.28555774 g/mol |
| Monoisotopic Mass | 474.28555774 g/mol |
| Topological Polar Surface Area | 91.2 Ų |
| Heavy Atom Count | 35 |
| Formal Charge | 0 |
| Complexity | 750 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Lerociclib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lerociclib, including repackagers and relabelers. The FDA regulates Lerociclib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lerociclib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Lerociclib supplier is an individual or a company that provides Lerociclib active pharmaceutical ingredient (API) or Lerociclib finished formulations upon request. The Lerociclib suppliers may include Lerociclib API manufacturers, exporters, distributors and traders.
Lerociclib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lerociclib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lerociclib GMP manufacturer or Lerociclib GMP API supplier for your needs.
A Lerociclib CoA (Certificate of Analysis) is a formal document that attests to Lerociclib's compliance with Lerociclib specifications and serves as a tool for batch-level quality control.
Lerociclib CoA mostly includes findings from lab analyses of a specific batch. For each Lerociclib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lerociclib may be tested according to a variety of international standards, such as European Pharmacopoeia (Lerociclib EP), Lerociclib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lerociclib USP).
LOOKING FOR A SUPPLIER?
